Neurobiological alteration in agitation in Alzheimer's disease and possible interventions

被引:1
|
作者
Rao, Jagadeesh S. [1 ]
Tangarife, Maria Alejandra [1 ]
Mukunda, Ram [1 ]
机构
[1] India Globalizat Capital IGC Pharm, Sci Dept, Potomac, MD 20859 USA
来源
FRONTIERS IN PSYCHIATRY | 2024年 / 15卷
关键词
agitation; Alzheimer's disease; neuroinflammation; GABA; CBR-1; THC; melatonin; SYMPTOMS; DRONABINOL; CORTEX; GABA;
D O I
10.3389/fpsyt.2024.1412901
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [1] Neurobiological aspects of Alzheimer's disease
    Chopra, Kanwaljit
    Misra, Shubham
    Kuhad, Anurag
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (05) : 535 - 555
  • [2] Management of agitation and aggression associated with Alzheimer's disease: controversies and possible solutions
    Ballard, Clive
    Corbett, Anne
    Chitramohan, Ramilgan
    Aarsland, Das
    CURRENT OPINION IN PSYCHIATRY, 2009, 22 (06) : 532 - 540
  • [3] Cannabinoids for Agitation in Alzheimer's Disease
    Outen, John D.
    Burhanullah, M. Haroon
    Vandrey, Ryan
    Amjad, Halima
    Harper, David G.
    Patrick, Regan E.
    May, Rose L.
    Agronin, Marc E.
    Forester, Brent P.
    Rosenberg, Paul B.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (12): : 1253 - 1263
  • [4] Frontoparietal Network Alteration as a Possible Biomarker to Predict Alzheimer's Disease
    Parikh, Vinay
    Strupp, Jacob
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 465 - 466
  • [5] Neurobiological early diagnosis of Alzheimer's disease
    Hampel, H.
    Teipel, S. J.
    Buerger, K.
    NERVENARZT, 2007, 78 (11): : 1310 - +
  • [6] Neurobiological basis of BPSD in Alzheimer's disease
    Meguro, K
    Tomoko, T
    Tashiro, M
    Tanaka, Y
    Ishii, H
    Itoh, M
    NEW TRENDS IN ALZHEIMER AND PARKINSON RELATED DISORDERS: ADPD 2005, 2005, : 231 - 233
  • [7] Disentangling the Treatment of Agitation in Alzheimer's Disease
    Howard, Robert J.
    AMERICAN JOURNAL OF PSYCHIATRY, 2016, 173 (05): : 441 - 443
  • [8] Quetiapine and rivastigmine for agitation in Alzheimer’s disease
    Raymond L. Ownby
    Current Psychiatry Reports, 2006, 8 (1) : 10 - 10
  • [9] Donepezil for the treatment of agitation in Alzheimer's disease
    Howard, Robert J.
    Juszczak, Edmund
    Ballard, Clive G.
    Bentham, Peter
    Brown, Richard G.
    Bullock, Roger
    Burns, Alistair S.
    Holmes, Clive
    Jacoby, Robin
    Johnson, Tony
    Knapp, Martin
    Lindesay, James
    O'Brien, John T.
    Wilcock, Gordon
    Katona, Cornelius
    Jones, Roy W.
    DeCesare, Julia
    Rodger, Michaela
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (14): : 1382 - 1392
  • [10] Commentary on "Cannabinoids for Agitation in Alzheimer's Disease"
    Goveas, Joseph S.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2021, 29 (12): : 1264 - 1266